Protective effects of clarithromycin in rats with hypoxia/reoxygenation-induced intestinal injury.
Özdemir
Özmert M A
ÖM
Department of Pediatrics, Faculty of Medicine, Pamukkale University, 20100 Denizli, Turkey. drozmert@gmail.com
Ergin
Hacer
H
Yenisey
Çiğdem
Ç
Türk
Nilay Şen
NŞ
Şimşek
Nilüfer Genç
NG
D000818:Animals; D000831:Animals, Newborn; D017291:Clarithromycin / Q000008:administration & dosage*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D020345:Enterocolitis, Necrotizing / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D005978:Glutathione / Q000378:metabolism; D007082:Ileum / Q000098:blood supply; D007279:Injections, Subcutaneous; D007413:Intestinal Mucosa / Q000378:metabolism / Q000473:pathology; D015227:Lipid Peroxidation / Q000187:drug effects; D008315:Malondialdehyde / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects*; D011500:Protein Synthesis Inhibitors / Q000008:administration & dosage*; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000150:complications / Q000378:metabolism / Q000473:pathology; D016896:Treatment Outcome
D011500:Protein Synthesis Inhibitors; D009569:Nitric Oxide; D008315:Malondialdehyde; D005978:Glutathione; D017291:Clarithromycin